- Press releases
- Country: United States
Mozart Therapeutics Presents Clinical and Preclinical Data Supporting MTX-101 at the 62nd EASD Annual Meeting
Presentations highlight Phase 1 clinical findings, proof-of-mechanism data, and translational evidence supporting the therapeutic potential of MTX-101 in adults and adolescents with Stage 3 type 1 diabetes SEATTLE, Oct. 5, 2026 /PRNewswire/ -- Mozart Therapeutics, Inc. ("Mozart"), the...